OMEPRAZOL ZENTIVA 40mg powder for solution for infusion
Active substance: omeprazole
Indicated for: peptic ulcer; gastroesophageal reflux
Find medicines for human use by name or active substance.
Browse by initial
401–420 of 852 medicines
Active substance: omeprazole
Indicated for: peptic ulcer; gastroesophageal reflux
Active substance: omeprazole
Indicated for: peptic ulcer; gastroesophageal reflux
Active substance: omeprazole
Indicated for: peptic ulcer; gastroesophageal reflux
Active substance: omeprazole
Indicated for: peptic ulcer; gastroesophageal reflux
Active substance: omeprazole
Indicated for: peptic ulcer; gastroesophageal reflux
Active substance: omeprazole
Indicated for: peptic ulcer; gastroesophageal reflux
Active substance: omeprazole
Indicated for: peptic ulcer; gastroesophageal reflux
Active substance: omeprazole
Indicated for: peptic ulcer; gastroesophageal reflux
Active substance: omeprazole
Indicated for: peptic ulcer; gastroesophageal reflux
Active substance: omeprazole
Indicated for: peptic ulcer; gastroesophageal reflux
Active substance: omeprazole
Indicated for: peptic ulcer; gastroesophageal reflux
Active substance: omeprazole
Indicated for: peptic ulcer; gastroesophageal reflux
Active substance: itraconazole
Indicated for: fungal infections
Active substance: omega-3-ethyl esters 90
Indicated for: hypertriglyceridemia
Active substance: omalizumab
R03DX05 Respiratory system | Other systemic drugs for obstructive airway diseases
Indicated for: severe allergic asthma; chronic spontaneous urticaria; chronic rhinosinusitis with nasal polyps
Active substance: omalizumab
R03DX05 Respiratory system | Other systemic drugs for obstructive airway diseases
Indicated for: severe allergic asthma; chronic spontaneous urticaria; chronic rhinosinusitis with nasal polyps
Active substance: omalizumab
R03DX05 Respiratory system | Other systemic drugs for obstructive airway diseases
Indicated for: severe allergic asthma; chronic spontaneous urticaria; chronic rhinosinusitis with nasal polyps
Active substance: omalizumab
R03DX05 Respiratory system | Other systemic drugs for obstructive airway diseases
Indicated for: severe allergic asthma; chronic spontaneous urticaria; chronic rhinosinusitis with nasal polyps
Active substance: omalizumab
R03DX05 Respiratory system | Other systemic drugs for obstructive airway diseases
Indicated for: severe allergic asthma; chronic spontaneous urticaria; chronic rhinosinusitis with nasal polyps
Active substance: omalizumab
R03DX05 Respiratory system | Other systemic drugs for obstructive airway diseases
Indicated for: severe allergic asthma; chronic spontaneous urticaria; chronic rhinosinusitis with nasal polyps
WHO (World Health Organization): Any substance or product that is used or is intended to be used to alter a physiological system or a pathological condition in the recipient's benefit.
Medicinal product: A substance or combination of substances used to treat or prevent disease, to restore, correct or modify physiological functions through pharmacological, immunological or metabolic action, or to make a medical diagnosis.
Active ingredient: A substance used in a medicine to produce a pharmacological, immunological or metabolic effect that restores, corrects or modifies physiological functions.
Excipients: Ingredients in a medicine other than its active substance. They can help stabilise the medicine or deliver the active substance to its intended site of action.
Original medicine: A medicine first authorised on the basis of a full dossier documenting its quality, safety and efficacy. It may serve as the reference medicine for a generic product.
Generic medicine: A medicine developed to be equivalent to an authorised reference medicine. It contains the same active substance or substances and is used at the same doses to treat the same diseases. Its inactive ingredients, name, appearance and packaging may differ.